Metastatic Prostate Cancer Treatment and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Metastatic Prostate Cancer Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Metastatic Prostate Cancer Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Metastatic Prostate Cancer Treatment Overall Market Size
2.1 Global Metastatic Prostate Cancer Treatment Market Size: 2021 VS 2028
2.2 Global Metastatic Prostate Cancer Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Metastatic Prostate Cancer Treatment Players in Global Market
3.2 Top Global Metastatic Prostate Cancer Treatment Companies Ranked by Revenue
3.3 Global Metastatic Prostate Cancer Treatment Revenue by Companies
3.4 Top 3 and Top 5 Metastatic Prostate Cancer Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Metastatic Prostate Cancer Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Metastatic Prostate Cancer Treatment Players in Global Market
3.6.1 List of Global Tier 1 Metastatic Prostate Cancer Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Metastatic Prostate Cancer Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Metastatic Prostate Cancer Treatment Market Size Markets, 2021 & 2028
4.1.2 Mono
4.1.3 Combination
4.1.4 Mono/Combination
4.2 By Type - Global Metastatic Prostate Cancer Treatment Revenue & Forecasts
4.2.1 By Type - Global Metastatic Prostate Cancer Treatment Revenue, 2017-2022
4.2.2 By Type - Global Metastatic Prostate Cancer Treatment Revenue, 2023-2028
4.2.3 By Type - Global Metastatic Prostate Cancer Treatment Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Metastatic Prostate Cancer Treatment Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Drug Store
5.1.4 Online Pharmacy
5.2 By Application - Global Metastatic Prostate Cancer Treatment Revenue & Forecasts
5.2.1 By Application - Global Metastatic Prostate Cancer Treatment Revenue, 2017-2022
5.2.2 By Application - Global Metastatic Prostate Cancer Treatment Revenue, 2023-2028
5.2.3 By Application - Global Metastatic Prostate Cancer Treatment Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Metastatic Prostate Cancer Treatment Market Size, 2021 & 2028
6.2 By Region - Global Metastatic Prostate Cancer Treatment Revenue & Forecasts
6.2.1 By Region - Global Metastatic Prostate Cancer Treatment Revenue, 2017-2022
6.2.2 By Region - Global Metastatic Prostate Cancer Treatment Revenue, 2023-2028
6.2.3 By Region - Global Metastatic Prostate Cancer Treatment Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Metastatic Prostate Cancer Treatment Revenue, 2017-2028
6.3.2 US Metastatic Prostate Cancer Treatment Market Size, 2017-2028
6.3.3 Canada Metastatic Prostate Cancer Treatment Market Size, 2017-2028
6.3.4 Mexico Metastatic Prostate Cancer Treatment Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Metastatic Prostate Cancer Treatment Revenue, 2017-2028
6.4.2 Germany Metastatic Prostate Cancer Treatment Market Size, 2017-2028
6.4.3 France Metastatic Prostate Cancer Treatment Market Size, 2017-2028
6.4.4 U.K. Metastatic Prostate Cancer Treatment Market Size, 2017-2028
6.4.5 Italy Metastatic Prostate Cancer Treatment Market Size, 2017-2028
6.4.6 Russia Metastatic Prostate Cancer Treatment Market Size, 2017-2028
6.4.7 Nordic Countries Metastatic Prostate Cancer Treatment Market Size, 2017-2028
6.4.8 Benelux Metastatic Prostate Cancer Treatment Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Metastatic Prostate Cancer Treatment Revenue, 2017-2028
6.5.2 China Metastatic Prostate Cancer Treatment Market Size, 2017-2028
6.5.3 Japan Metastatic Prostate Cancer Treatment Market Size, 2017-2028
6.5.4 South Korea Metastatic Prostate Cancer Treatment Market Size, 2017-2028
6.5.5 Southeast Asia Metastatic Prostate Cancer Treatment Market Size, 2017-2028
6.5.6 India Metastatic Prostate Cancer Treatment Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Metastatic Prostate Cancer Treatment Revenue, 2017-2028
6.6.2 Brazil Metastatic Prostate Cancer Treatment Market Size, 2017-2028
6.6.3 Argentina Metastatic Prostate Cancer Treatment Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Metastatic Prostate Cancer Treatment Revenue, 2017-2028
6.7.2 Turkey Metastatic Prostate Cancer Treatment Market Size, 2017-2028
6.7.3 Israel Metastatic Prostate Cancer Treatment Market Size, 2017-2028
6.7.4 Saudi Arabia Metastatic Prostate Cancer Treatment Market Size, 2017-2028
6.7.5 UAE Metastatic Prostate Cancer Treatment Market Size, 2017-2028
7 Players Profiles
7.1 AB Science
7.1.1 AB Science Corporate Summary
7.1.2 AB Science Business Overview
7.1.3 AB Science Metastatic Prostate Cancer Treatment Major Product Offerings
7.1.4 AB Science Metastatic Prostate Cancer Treatment Revenue in Global Market (2017-2022)
7.1.5 AB Science Key News
7.2 BeiGene
7.2.1 BeiGene Corporate Summary
7.2.2 BeiGene Business Overview
7.2.3 BeiGene Metastatic Prostate Cancer Treatment Major Product Offerings
7.2.4 BeiGene Metastatic Prostate Cancer Treatment Revenue in Global Market (2017-2022)
7.2.5 BeiGene Key News
7.3 eFFECTOR Therapeutics
7.3.1 eFFECTOR Therapeutics Corporate Summary
7.3.2 eFFECTOR Therapeutics Business Overview
7.3.3 eFFECTOR Therapeutics Metastatic Prostate Cancer Treatment Major Product Offerings
7.3.4 eFFECTOR Therapeutics Metastatic Prostate Cancer Treatment Revenue in Global Market (2017-2022)
7.3.5 eFFECTOR Therapeutics Key News
7.4 Immunomedics(Gilead Sciences, Inc.)
7.4.1 Immunomedics(Gilead Sciences, Inc.) Corporate Summary
7.4.2 Immunomedics(Gilead Sciences, Inc.) Business Overview
7.4.3 Immunomedics(Gilead Sciences, Inc.) Metastatic Prostate Cancer Treatment Major Product Offerings
7.4.4 Immunomedics(Gilead Sciences, Inc.) Metastatic Prostate Cancer Treatment Revenue in Global Market (2017-2022)
7.4.5 Immunomedics(Gilead Sciences, Inc.) Key News
7.5 Myovant Biosciences
7.5.1 Myovant Biosciences Corporate Summary
7.5.2 Myovant Biosciences Business Overview
7.5.3 Myovant Biosciences Metastatic Prostate Cancer Treatment Major Product Offerings
7.5.4 Myovant Biosciences Metastatic Prostate Cancer Treatment Revenue in Global Market (2017-2022)
7.5.5 Myovant Biosciences Key News
7.6 SeleXel
7.6.1 SeleXel Corporate Summary
7.6.2 SeleXel Business Overview
7.6.3 SeleXel Metastatic Prostate Cancer Treatment Major Product Offerings
7.6.4 SeleXel Metastatic Prostate Cancer Treatment Revenue in Global Market (2017-2022)
7.6.5 SeleXel Key News
7.7 Zenith Epigenetics Ltd.
7.7.1 Zenith Epigenetics Ltd. Corporate Summary
7.7.2 Zenith Epigenetics Ltd. Business Overview
7.7.3 Zenith Epigenetics Ltd. Metastatic Prostate Cancer Treatment Major Product Offerings
7.7.4 Zenith Epigenetics Ltd. Metastatic Prostate Cancer Treatment Revenue in Global Market (2017-2022)
7.7.5 Zenith Epigenetics Ltd. Key News
7.8 VasGene Therapeutics, Inc.
7.8.1 VasGene Therapeutics, Inc. Corporate Summary
7.8.2 VasGene Therapeutics, Inc. Business Overview
7.8.3 VasGene Therapeutics, Inc. Metastatic Prostate Cancer Treatment Major Product Offerings
7.8.4 VasGene Therapeutics, Inc. Metastatic Prostate Cancer Treatment Revenue in Global Market (2017-2022)
7.8.5 VasGene Therapeutics, Inc. Key News
7.9 Telix Pharmaceuticals
7.9.1 Telix Pharmaceuticals Corporate Summary
7.9.2 Telix Pharmaceuticals Business Overview
7.9.3 Telix Pharmaceuticals Metastatic Prostate Cancer Treatment Major Product Offerings
7.9.4 Telix Pharmaceuticals Metastatic Prostate Cancer Treatment Revenue in Global Market (2017-2022)
7.9.5 Telix Pharmaceuticals Key News
7.10 Arvinas Inc.
7.10.1 Arvinas Inc. Corporate Summary
7.10.2 Arvinas Inc. Business Overview
7.10.3 Arvinas Inc. Metastatic Prostate Cancer Treatment Major Product Offerings
7.10.4 Arvinas Inc. Metastatic Prostate Cancer Treatment Revenue in Global Market (2017-2022)
7.10.5 Arvinas Inc. Key News
7.11 Amgen
7.11.1 Amgen Corporate Summary
7.11.2 Amgen Business Overview
7.11.3 Amgen Metastatic Prostate Cancer Treatment Major Product Offerings
7.11.4 Amgen Metastatic Prostate Cancer Treatment Revenue in Global Market (2017-2022)
7.11.5 Amgen Key News
7.12 Genentech
7.12.1 Genentech Corporate Summary
7.12.2 Genentech Business Overview
7.12.3 Genentech Metastatic Prostate Cancer Treatment Major Product Offerings
7.12.4 Genentech Metastatic Prostate Cancer Treatment Revenue in Global Market (2017-2022)
7.12.5 Genentech Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Metastatic Prostate Cancer Treatment Market Opportunities & Trends in Global Market
Table 2. Metastatic Prostate Cancer Treatment Market Drivers in Global Market
Table 3. Metastatic Prostate Cancer Treatment Market Restraints in Global Market
Table 4. Key Players of Metastatic Prostate Cancer Treatment in Global Market
Table 5. Top Metastatic Prostate Cancer Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Metastatic Prostate Cancer Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Metastatic Prostate Cancer Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Metastatic Prostate Cancer Treatment Product Type
Table 9. List of Global Tier 1 Metastatic Prostate Cancer Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Metastatic Prostate Cancer Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Metastatic Prostate Cancer Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Metastatic Prostate Cancer Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Metastatic Prostate Cancer Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Metastatic Prostate Cancer Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Metastatic Prostate Cancer Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Metastatic Prostate Cancer Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Metastatic Prostate Cancer Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Metastatic Prostate Cancer Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Metastatic Prostate Cancer Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Metastatic Prostate Cancer Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Metastatic Prostate Cancer Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Metastatic Prostate Cancer Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Metastatic Prostate Cancer Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Metastatic Prostate Cancer Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Metastatic Prostate Cancer Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Metastatic Prostate Cancer Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Metastatic Prostate Cancer Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Metastatic Prostate Cancer Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Metastatic Prostate Cancer Treatment Revenue, (US$, Mn), 2023-2028
Table 30. AB Science Corporate Summary
Table 31. AB Science Metastatic Prostate Cancer Treatment Product Offerings
Table 32. AB Science Metastatic Prostate Cancer Treatment Revenue (US$, Mn), (2017-2022)
Table 33. BeiGene Corporate Summary
Table 34. BeiGene Metastatic Prostate Cancer Treatment Product Offerings
Table 35. BeiGene Metastatic Prostate Cancer Treatment Revenue (US$, Mn), (2017-2022)
Table 36. eFFECTOR Therapeutics Corporate Summary
Table 37. eFFECTOR Therapeutics Metastatic Prostate Cancer Treatment Product Offerings
Table 38. eFFECTOR Therapeutics Metastatic Prostate Cancer Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Immunomedics(Gilead Sciences, Inc.) Corporate Summary
Table 40. Immunomedics(Gilead Sciences, Inc.) Metastatic Prostate Cancer Treatment Product Offerings
Table 41. Immunomedics(Gilead Sciences, Inc.) Metastatic Prostate Cancer Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Myovant Biosciences Corporate Summary
Table 43. Myovant Biosciences Metastatic Prostate Cancer Treatment Product Offerings
Table 44. Myovant Biosciences Metastatic Prostate Cancer Treatment Revenue (US$, Mn), (2017-2022)
Table 45. SeleXel Corporate Summary
Table 46. SeleXel Metastatic Prostate Cancer Treatment Product Offerings
Table 47. SeleXel Metastatic Prostate Cancer Treatment Revenue (US$, Mn), (2017-2022)
Table 48. Zenith Epigenetics Ltd. Corporate Summary
Table 49. Zenith Epigenetics Ltd. Metastatic Prostate Cancer Treatment Product Offerings
Table 50. Zenith Epigenetics Ltd. Metastatic Prostate Cancer Treatment Revenue (US$, Mn), (2017-2022)
Table 51. VasGene Therapeutics, Inc. Corporate Summary
Table 52. VasGene Therapeutics, Inc. Metastatic Prostate Cancer Treatment Product Offerings
Table 53. VasGene Therapeutics, Inc. Metastatic Prostate Cancer Treatment Revenue (US$, Mn), (2017-2022)
Table 54. Telix Pharmaceuticals Corporate Summary
Table 55. Telix Pharmaceuticals Metastatic Prostate Cancer Treatment Product Offerings
Table 56. Telix Pharmaceuticals Metastatic Prostate Cancer Treatment Revenue (US$, Mn), (2017-2022)
Table 57. Arvinas Inc. Corporate Summary
Table 58. Arvinas Inc. Metastatic Prostate Cancer Treatment Product Offerings
Table 59. Arvinas Inc. Metastatic Prostate Cancer Treatment Revenue (US$, Mn), (2017-2022)
Table 60. Amgen Corporate Summary
Table 61. Amgen Metastatic Prostate Cancer Treatment Product Offerings
Table 62. Amgen Metastatic Prostate Cancer Treatment Revenue (US$, Mn), (2017-2022)
Table 63. Genentech Corporate Summary
Table 64. Genentech Metastatic Prostate Cancer Treatment Product Offerings
Table 65. Genentech Metastatic Prostate Cancer Treatment Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Metastatic Prostate Cancer Treatment Segment by Type in 2021
Figure 2. Metastatic Prostate Cancer Treatment Segment by Application in 2021
Figure 3. Global Metastatic Prostate Cancer Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Metastatic Prostate Cancer Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Metastatic Prostate Cancer Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Metastatic Prostate Cancer Treatment Revenue in 2021
Figure 8. By Type - Global Metastatic Prostate Cancer Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Metastatic Prostate Cancer Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Metastatic Prostate Cancer Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Metastatic Prostate Cancer Treatment Revenue Market Share, 2017-2028
Figure 12. US Metastatic Prostate Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Metastatic Prostate Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Metastatic Prostate Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Metastatic Prostate Cancer Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Metastatic Prostate Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Metastatic Prostate Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Metastatic Prostate Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Metastatic Prostate Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Metastatic Prostate Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Metastatic Prostate Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Metastatic Prostate Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Metastatic Prostate Cancer Treatment Revenue Market Share, 2017-2028
Figure 24. China Metastatic Prostate Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Metastatic Prostate Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Metastatic Prostate Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Metastatic Prostate Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Metastatic Prostate Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Metastatic Prostate Cancer Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Metastatic Prostate Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Metastatic Prostate Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Metastatic Prostate Cancer Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Metastatic Prostate Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Metastatic Prostate Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Metastatic Prostate Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Metastatic Prostate Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. AB Science Metastatic Prostate Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. BeiGene Metastatic Prostate Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. eFFECTOR Therapeutics Metastatic Prostate Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Immunomedics(Gilead Sciences, Inc.) Metastatic Prostate Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Myovant Biosciences Metastatic Prostate Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. SeleXel Metastatic Prostate Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Zenith Epigenetics Ltd. Metastatic Prostate Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. VasGene Therapeutics, Inc. Metastatic Prostate Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Telix Pharmaceuticals Metastatic Prostate Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Arvinas Inc. Metastatic Prostate Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Amgen Metastatic Prostate Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Genentech Metastatic Prostate Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Industry Market Size
